3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
5
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Head and Neck Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
11
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Neoplasms
4
Melanoma
4
Laryngeal Diseases
4
Carcinoma
3
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Neoplasms, Squamous Cell
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Hypopharyngeal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Interventions
Cetuximab
14
Cisplatin
12
pembrolizumab
11
Paclitaxel
9
Gemcitabine
9
durvalumab
6
Nivolumab
6
Docetaxel
6
toripalimab
5
Carboplatin
5
Radiotherapy
4
Fluorouracil
4
Cyclophosphamide
4
fludarabine
3
Valproic Acid
3
Capecitabine
3
tremelimumab
2
spartalizumab
2
nimotuzumab
2
irinotecan sucrosofate
2
fludarabine phosphate
2
cemiplimab
2
anlotinib
2
Sunitinib
2
S 1 (combination)
2
Radiation
2
Oxaliplatin
2
NVP-BKM120
2
Methotrexate
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Pemetrexed
×
Head & Neck
×
Clear all
NCT00786552
2011-01-20
Panthera
University Hospital Schleswig-Holstein
Phase 2
Unknown
47 enrolled